World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
77
Citations
18025
World Ranking
1368
National Ranking
117

Stephen H. Gillespie publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Stephen H. Gillespie sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 360 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Stephen H. Gillespie D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen H. Gillespie sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 77 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Stephen H. Gillespie is affiliated with the University of St Andrews in the United Kingdom and has contributed extensively to the field of medicine, with a focus on epidemiology and infectious diseases. Their research spans several interconnected areas including tuberculosis, bacterial identification, antibiotic resistance, and respiratory infections.

The scientist's main fields of study include:

  • Medicine

Within this broad field, Gillespie's subfields of study are:

  • Epidemiology
  • Infectious Diseases
  • Clinical Biochemistry
  • Surgery
  • Applied Microbiology and Biotechnology

Their work primarily addresses topics such as:

  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • Bacterial Identification and Susceptibility Testing
  • Antibiotic Use and Resistance
  • Pneumonia and Respiratory Infections
  • Urinary Tract Infections Management
  • Global Maternal and Child Health

Stephen H. Gillespie has published in a variety of venues, frequently contributing to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • The International Journal of Tuberculosis and Lung Disease
  • The Lancet Microbe
  • Frontiers in Antibiotics

Recent notable papers include:

  • "Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay," 2020, Thorax
  • "Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies," 2022, Clinical Microbiology Reviews
  • "The role of multidimensional poverty in antibiotic misuse: a mixed-methods study of self-medication and non-adherence in Kenya, Tanzania, and Uganda," 2022, The Lancet Global Health
  • "Update on the diagnosis of tuberculosis," 2023, Clinical Microbiology and Infection
  • "Perspective for Precision Medicine for Tuberculosis," 2020, Frontiers in Immunology

Frequent co-authors collaborating with Gillespie comprise:

  • Wilber Sabiiti
  • Derek J. Sloan
  • Matthew T. G. Holden
  • Gibson Kibiki
  • Stephen E. Mshana

Best Publications

  • Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis

    Stephen H. Gillespie;Angela M. Crook;Timothy D. McHugh;Carl M. Mendel

  • Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective

    Stephen H. Gillespie

  • Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology

    Claudio U. Köser;Matthew J. Ellington;Edward J. P. Cartwright;Edward J. P. Cartwright;Stephen H. Gillespie

  • Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial

    C Chintu;GJ Bhat;AS Walker;V Mulenga

  • The bacteriology of pleural infection by genetic and standard methods and its mortality significance.

    Nick A. Maskell;Sarah Batt;Emma L. Hedley;Christopher W. H. Davies

  • New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

    Alimuddin I Zumla;Alimuddin I Zumla;Stephen H Gillespie;Michael Hoelscher;Patrick P J Philips

  • High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

    Martin J Boeree;Norbert Heinrich;Rob Aarnoutse;Andreas H Diacon

  • A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis

    M.J. Boeree;A.H. Diacon;R. Dawson;K. Narunsky

  • Physiological Cost of Rifampin Resistance Induced In Vitro in Mycobacterium tuberculosis

    O. J. Billington;T. D. McHugh;S. H. Gillespie

  • Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment

    Jakko van Ingen;Rob E. Aarnoutse;Peter R. Donald;Andreas H. Diacon

  • The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis

    Roly D. Gosling;Leonard O. Uiso;Noel E. Sam;Emily Bongard

  • Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study

    Josephine M Bryant;Simon R Harris;Julian Parkhill;Rodney Dawson

  • Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

    Sven O. Friedrich;Andrea Rachow;Andrea Rachow;Elmar Saathoff;Kasha Singh

  • Gram-positive cocci

    Unknown

  • Blood culture bottle culture of pleural fluid in pleural infection

    S. M. Menzies;N. M. Rahman;J. M. Wrightson;H. E. Davies

  • Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution.

    T. Yeghen;C. C. Kibbler;H. G. Prentice;L. A. Berger

  • Anti-tuberculosis medication and the liver: dangers and recommendations in management

    N P Thompson;M E Caplin;M I Hamilton;S H Gillespie

  • Principles and Practice of Clinical Bacteriology

    Stephen Gillespie;Peter M Hawkey

  • Activity of moxifloxacin against mycobacteria.

    S. H. Gillespie;O. Billington

  • Molecular epidemiology of tuberculosis in London 1995–7 showing low rate of active transmission

    H Maguire;J W Dale;T D McHugh;P D Butcher

  • Principles and practice of clinical parasitology

    Stephen H. Gillespie;Richard D. Pearson

  • Pathogenesis of pneumococcal infection.

    S.H. Gillespie;I. Balakrishnan

  • Mandell, Douglas, and Bennett's principles and practice of infectious diseases

    Stephen H Gillespie

Frequent Co-Authors

Timothy D. McHugh
Timothy D. McHugh University College London
Andrew Nunn
Andrew Nunn University College London
Michael Hoelscher
Michael Hoelscher Ludwig-Maximilians-Universität München
Marc Lipman
Marc Lipman Royal Free London NHS Foundation Trust
Anne Osbourn
Anne Osbourn John Innes Centre
Geoffrey L. Smith
Geoffrey L. Smith University of Oxford
Michael E. P. Murphy
Michael E. P. Murphy University of British Columbia
Matthew T. G. Holden
Matthew T. G. Holden University of St Andrews
Kishan Dholakia
Kishan Dholakia University of St Andrews
Roly Gosling
Roly Gosling University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Microbiology opens doors to various related fields and career options, many of which offer flexible online learning opportunities. For those interested in expanding their knowledge in health sciences, exploring online medical programs can be a convenient way to gain essential expertise without relocating.

Public health is another popular pathway closely tied to microbiology. Many students look for the best easiest mph online programs to get into, allowing for a smoother transition into public health careers that often collaborate with microbiologists on health initiatives and disease prevention.

For individuals passionate about working with children, considering a career as a child life specialist may be appealing. The role’s salary and growth potential are detailed in resources about child life specialists salary, making it easier to evaluate this fulfilling career path.

Importantly, those with diverse backgrounds, including individuals with prior convictions, can also advance their education. The best degrees for felons include options that pave the way to careers in health and science, expanding opportunities for all learners.

Best Scientists Citing Stephen H. Gillespie

Trending Scientists

Recently Published Articles